Lilyana Amezcua, MD

Title(s)Associate Professor of Clinical Neurology
SchoolKeck School of Medicine of Usc
AddressGNH Eeg 4aye114
Off Campus
Los Angeles CA 90089-9315
Phone+1 323 409 3439
vCardDownload vCard
    Other Positions
    Title(s)Program Director, Multiple Sclerosis Fellowship

    Title(s)Director, Keck Huntington Beach Multiple Sclerosis Infusion Program

    Title(s)Department of Neurology DEI Champion


    Collapse Biography 
    Collapse Awards and Honors
    Consortium of Multiple Sclerosis Centers2016Best Platform: Patient and Family Education
    American Academy of Neurology2019Fellow of the American Academy of Neurology
    National Multiple Sclerosis Society2022Healthcare Physician Champion Award

    Collapse Overview 
    Collapse Overview
    Dr. Amezcua is an Associate Professor of Neurology, Diversity, Equity and Inclusion Champion, and the fellowship program director at the University of Southern California (USC), Keck School of Medicine. She received her Bachelor of Science degree from University of California Irvine in Irvine, California, her medical degree from Jefferson Medical College in Philadelphia, Pennsylvania, followed by neurology residency and clinical fellowship in neuroimmunology and multiple sclerosis at USC. She received her Master of Science degree in clinical, biomedical, and translational science from USC, Preventive Medicine, under a Clinical Translational Science Institute NIH KL2 award.

    She spearheaded the collaborative research consortium: Alliance for Research in Hispanic MS (ARHMS) and serves as principal investigator. ARHMS is geared at better defining racial and ethnic health disparities, by examining modifiable (social determinants of health and environmental) from non-modifiable genetic factors involved in disease severity and progression specific to the Hispanic and Latino population affected with MS. She serves in numerous national and international committees including as an elected member to the NMSS National Medical Advisory Committee (NMAC), American Academy of Neurology Quality Measures for MS, and NIH NINDS Health Disparities Strategic Steering Committee. She has been recognized with numerous awards with most recent one as the NMSS Health Care Champion.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Faculty Mentoring
    Collapse Required Scholarly Project Mentor

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health. Curr Opin Neurol. 2024 Mar 21. Robers MV, Amezcua L. PMID: 38506756.
      View in: PubMed   Mentions:    Fields:    
    2. Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort Neurology. 2024 02 27; 102(4):e208100. Radzik AM, Amezcua L, Anderson A, Gilmore S, Ahmad S, Brandstadter R, Fabian MT, Graham EL, Hodgkinson S, Horton L, Jacobs DA, Katz Sand IB, Kohli A, Levine L, McLemore M, Okai AF, Patel J, Poole S, Riley C, Satyanarayan S, Tardo L, Verter E, Villacorta V, Zimmerman V, Zuroff L, Williams MJ, Houtchens MK, Bove R. PMID: 38261988; PMCID: PMC10962915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. A tale of race and B cells in multiple sclerosis. Nat Rev Neurol. 2024 01; 20(1):5-6. Orlando CM, Amezcua L. PMID: 37990136.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Tuberculous Meningitis or Neurosarcoidosis-a Diagnostic Quandary. From the National Multiple Sclerosis Society Case Conference Proceedings Neurol Neuroimmunol Neuroinflamm. 2024 01; 11(1):e200184. Lin J, Pulst-Korenberg J, Zamvil SS, Graves J, Newsome SD, Amezcua L. PMID: 38118077; PMCID: PMC10732344.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Inclusion of optic neuritis in dissemination in space improves the performance of McDonald 2017 criteria in Hispanic people with suspected multiple sclerosis. Mult Scler. 2023 Dec; 29(14):1748-1754. Amezcua L, Robers MV, Soneji D, Manouvakhova O, Martinez A, Islam T. PMID: 37942880; PMCID: PMC10841903.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Re-thinking race and geography in multiple sclerosis. Mult Scler. 2024 Jan; 30(1):16-18. Ontaneda D, Amezcua L. PMID: 37905533.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Diversity, Equity, and Inclusion in the Multiple Sclerosis Community: A Call to Action. Int J MS Care. 2023 Sep-Oct; 25(5):199-205. Hersh CM, Morrow SA, Williams MJ, Amezcua L, Halper J, Wandersee K. PMID: 37720263; PMCID: PMC10503818.
      View in: PubMed   Mentions:
    8. The impact of medical insurance on health care access and quality for people with multiple sclerosis in the United States: A scoping review. Mult Scler. 2024 Mar; 30(3):299-307. Moghavem N, Castañeda GDR, Chatfield AJ, Amezcua L. PMID: 37698024.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved. Neurol Clin. 2024 Feb; 42(1):295-317. Williams MJ, Orlando C, Akisanya J, Amezcua L. PMID: 37980120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Health Disparities Research Curricula and Training Development: Recommendations From a National Institute of Neurological Disorders and Stroke Workgroup. Neurology. 2023 08 15; 101(7 Suppl 1):S47-S58. Ovbiagele B, Amezcua L, Cruz-Flores SC, Griffith P, Jean-Louis G, Jenkins C, Howard VJ, Smith-Byrd G. PMID: 37580153.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Enhancing diversity of clinical trial populations in multiple sclerosis. Mult Scler. 2023 08; 29(9):1174-1185. Marrie RA, Chataway J, Bierer BE, Finlayson M, Martinez-Lapiscina EH, Panagoulias J, Sormani MP, Williams MJ, Amezcua L. PMID: 37555490; PMCID: PMC10413791.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol. 2023 08; 22(8):750-768. Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W, Waubant EL, Yamout B, Cohen JA. PMID: 37479377.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data. Mult Scler Relat Disord. 2023 Sep; 77:104866. Amezcua L, Livingston T, Hayward B, Zhou J, Williams MJ. PMID: 37487345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM. Neurol Ther. 2023 Oct; 12(5):1669-1682. Williams MJ, Amezcua L, Chinea A, Cohan S, Okai A, Okuda DT, Vargas W, Belviso N, Božin I, Jiang X, Lewin JB, Lyons J, Shen C, England SM, Grimes N. PMID: 37354276; PMCID: PMC10444730.
      View in: PubMed   Mentions:
    15. Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial. Mult Scler Relat Disord. 2023 Aug; 76:104794. Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E, Yap S, Ndrio J, Pei J, Mowry EM, Magrini F, Acosta J, Amezcua L, CHIMES investigators. PMID: 37356256.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    16. Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients. Front Immunol. 2023; 14:1172993. Telesford KM, Amezcua L, Tardo L, Horton L, Lund BT, Reder AT, Vartanian T, Monson NL. PMID: 37215103; PMCID: PMC10196635.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies. Neurol Ther. 2023 Jun; 12(3):883-897. Amezcua L, Mao-Draayer Y, Vargas WS, Farber R, Schaefer S, Branco F, England SM, Belviso N, Lewin JB, Mendoza JP, Shankar SL, ENDORSE Study Investigators. PMID: 37061656; PMCID: PMC10195942.
      View in: PubMed   Mentions:
    18. Multiple sclerosis in Indigenous Peoples of the Americas: A systematic review of incidence, prevalence, and outcomes. Mult Scler Relat Disord. 2023 Apr; 72:104612. Robers MV, Hurtubise B, Roberts MH, Robinson R, Schmidt H, Amezcua L. PMID: 36917888.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population. PLoS One. 2022; 17(12):e0279132. Beecham AH, Amezcua L, Chinea A, Manrique CP, Gomez L, Martinez A, Beecham GW, Patsopoulos NA, Chitnis T, Weiner HL, De Jager PL, Burchard EG, Lund BT, Fitzgerald KC, Calabresi PA, Delgado SR, Oksenberg JR, McCauley JL. PMID: 36548255; PMCID: PMC9778564.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. MOG Antibody-Associated Disease and Thymic Hyperplasia: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Hurtubise B, Frohman EM, Galetta S, Balcer LJ, Frohman TC, Lisak RP, Newsome SD, Graves JS, Zamvil SS, Amezcua L. PMID: 36517233; PMCID: PMC9753285.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023 03; 93(3):604-614. Okuda DT, Kantarci O, Lebrun-Frénay C, Sormani MP, Azevedo CJ, Bovis F, Hua LH, Amezcua L, Mowry EM, Hotermans C, Mendoza J, Walsh JS, von Hehn C, Vargas WS, Donlon S, Naismith RT, Okai A, Pardo G, Repovic P, Stüve O, Siva A, Pelletier D. PMID: 36401339.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    22. Epidemiologic trends of multiple sclerosis in Puerto Rico (2013-2020). Mult Scler Relat Disord. 2022 Dec; 68:104240. Chinea A, Ríos-Bedoya CF, Vicente I, Vega-Corteguera RJ, Martínez-Maldonado V, Carmona-Burgos DX, Rubí C, Amezcua L, Gilman CK, Díaz de la Matta PG, Rivera EP. PMID: 36544310.
      View in: PubMed   Mentions: 1     Fields:    
    23. Progressive Multiple Sclerosis. Continuum (Minneap Minn). 2022 08 01; 28(4):1083-1103. Amezcua L. PMID: 35938658.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Promoting Physical Activity in a Spanish-Speaking Latina Population of Low Socioeconomic Status With Chronic Neurological Disorders: Proof-of-Concept Study. JMIR Form Res. 2022 Apr 20; 6(4):e34312. Garbin A, Díaz J, Bui V, Morrison J, Fisher BE, Palacios C, Estrada-Darley I, Haase D, Wing D, Amezcua L, Jakowec MW, Kaplan C, Petzinger G. PMID: 35442197; PMCID: PMC9069293.
      View in: PubMed   Mentions:
    25. Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease. J Neuroophthalmol. 2022 06 01; 42(2):239-245. Hamza MM, Alas BF, Huang C, Quon JC, Amezcua L, Robers MV, Gokoffski KK. PMID: 35427281.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort. Mult Scler Relat Disord. 2022 Feb; 58:103451. Pimentel Maldonado DA, Eusebio JR, Amezcua L, Vasileiou ES, Mowry EM, Hemond CC, Umeton Pizzolato R, Berrios Morales I, Radu I, Ionete C, Fitzgerald KC. PMID: 34953410; PMCID: PMC9308106.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review. JAMA Neurol. 2021 12 01; 78(12):1515-1524. Amezcua L, Rivera VM, Vazquez TC, Baezconde-Garbanati L, Langer-Gould A. PMID: 34605866.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    28. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Neurol Clin Pract. 2021 Aug; 11(4):352-357. Hua LH, Obeidat AZ, Amezcua L, Cohen JA, Costello K, Dunn J, Gelfand JM, Goldman MD, Hopkins S, Jeffery D, Krieger S, Newsome SD, Shah S, Sicotte NL, Yadav V, Longbrake EE. PMID: 34484933; PMCID: PMC8382436.
      View in: PubMed   Mentions:
    29. Hypertension and hypertension severity in Hispanics/Latinx with MS. Mult Scler. 2021 10; 27(12):1894-1901. Robers MV, Chan C, Vajdi B, Chiong-Rivero H, Martinez A, Burnett ME, Ramanathan M, Amezcua L. PMID: 34197237.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis. Mult Scler J Exp Transl Clin. 2021 Jan-Mar; 7(1):2055217321995947. Chiong-Rivero H, Robers M, Martinez A, Manrique CP, Diaz A, Polito K, Vajdi B, Chan C, Burnett M, Delgado SR, Chinea A, McCauley JL, Amezcua L, ARHMS investigators. PMID: 33717502; PMCID: PMC7923991.
      View in: PubMed   Mentions: 5  
    31. Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemic. Mult Scler J Exp Transl Clin. 2021 Jan-Mar; 7(1):2055217321997467. McGinley MP, Gales S, Rowles W, Wang Z, Hsu WY, Amezcua L, Bove R. PMID: 33738110; PMCID: PMC7934057.
      View in: PubMed   Mentions: 7  
    32. Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups. Int J MS Care. 2021 Jul-Aug; 23(4):170-177. Pimentel Maldonado DA, Moreno A, Williams MJ, Amezcua L, Feliciano S, Williams A, Machemer D, Livingston T, LaRocque M, Glim M, Schmidt H. PMID: 34483756; PMCID: PMC8405146.
      View in: PubMed   Mentions: 8  
    33. Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada. Mult Scler. 2021 06; 27(7):1027-1036. Seyman E, Jones A, Guenette M, Vosoughi R, Selchen D, Amezcua L, Baral S, Oh J. PMID: 32779522.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM. Neurol Ther. 2020 Dec; 9(2):495-504. Chinea A, Amezcua L, Vargas W, Okai A, Williams MJ, Su R, Parks B, Mendoza JP, Lewin JB, Jones CC. PMID: 32472385; PMCID: PMC7606387.
      View in: PubMed   Mentions: 7  
    35. Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM. Neurol Ther. 2020 Dec; 9(2):483-493. Williams MJ, Amezcua L, Okai A, Okuda DT, Cohan S, Su R, Parks B, Mendoza JP, Lewin JB, Jones CC. PMID: 32472386; PMCID: PMC7606389.
      View in: PubMed   Mentions: 11  
    36. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis. Neurology. 2020 04 07; 94(14):e1548-e1556. Amezcua L, Smith JB, Gonzales EG, Haraszti S, Langer-Gould A. PMID: 32152131; PMCID: PMC7251526.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. Race and ethnicity on MS presentation and disease course. Mult Scler. 2020 04; 26(5):561-567. Amezcua L, McCauley JL. PMID: 31965878; PMCID: PMC7160002.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    38. Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study). Neurol Ther. 2019 Dec; 8(2):367-381. Okai AF, Amezcua L, Berkovich RR, Chinea AR, Edwards KR, Steingo B, Walker A, Jacobs AK, Daizadeh N, Williams MJ, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators. PMID: 31654272; PMCID: PMC6858901.
      View in: PubMed   Mentions: 2  
    39. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States. Mult Scler. 2020 10; 26(11):1329-1339. Beecham AH, Amezcua L, Chinea A, Manrique CP, Rubi C, Isobe N, Lund BT, Santaniello A, Beecham GW, Burchard EG, Comabella M, Patsopoulos N, Fitzgerald K, Calabresi PA, De Jager P, Conti DV, Delgado SR, Oksenberg JR, McCauley JL. PMID: 31368393; PMCID: PMC6994382.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    40. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2019 08; 40(8):1274-1281. Barisano G, Bigjahan B, Metting S, Cen S, Amezcua L, Lerner A, Toga AW, Law M. PMID: 31345942; PMCID: PMC7048477.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2019 09; 6(5):e583. Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR, Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC). PMID: 31355319; PMCID: PMC6624150.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    42. Women's Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines. 2019 Apr 19; 7(2). Tisovic K, Amezcua L. PMID: 31010259; PMCID: PMC6630249.
      View in: PubMed   Mentions: 3  
    43. Rituximab during pregnancy in neuromyelitis optica: A case report. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e542. Miranda-Acuña J, Rivas-Rodríguez E, Levy M, Ansari M, Stone R, Patel V, Amezcua L. PMID: 30800724; PMCID: PMC6384016.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis. Ann Clin Transl Neurol. 2018 Nov; 5(11):1362-1371. Amezcua L, Beecham AH, Delgado SR, Chinea A, Burnett M, Manrique CP, Gomez R, Comabella M, Montalban X, Ortega M, Tornes L, Lund BT, Islam T, Conti D, Oksenberg JR, McCauley JL. PMID: 30480030; PMCID: PMC6243381.
      View in: PubMed   Mentions: 12     Fields:    
    45. Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States. Neurol Clin. 2018 Feb; 36(1):151-162. Rivas-Rodríguez E, Amezcua L. PMID: 29157396.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    46. Multiple Sclerosis Mortality by Race/Ethnicity, Age, Sex, and Time Period in the United States, 1999-2015. Neuroepidemiology. 2018; 50(1-2):35-40. Amezcua L, Rivas E, Joseph S, Zhang J, Liu L. PMID: 29339633.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    47. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background. Acta Neurol Belg. 2018 Mar; 118(1):47-52. Rito Y, Flores J, Fernández-Aguilar A, Escalante-Membrillo C, Barboza MA, Amezcua L, Corona T. PMID: 28975580.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics. Neurotherapeutics. 2017 Oct; 14(4):945-951. Amezcua L, Nelson F. PMID: 28779373; PMCID: PMC5722765.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. MS in self-identified Hispanic/Latino individuals living in the US. Mult Scler J Exp Transl Clin. 2017 Jul-Sep; 3(3):2055217317725103. Amezcua L, Oksenberg JR, McCauley JL. PMID: 28979795; PMCID: PMC5617095.
      View in: PubMed   Mentions: 8  
    50. FOD Restoration for Enhanced Mapping of White Matter Lesion Connectivity. Med Image Comput Comput Assist Interv. 2017 Sep; 10433:584-592. Sun W, Amezcua L, Shi Y. PMID: 29046903; PMCID: PMC5643028.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology. 2017 Sep 26; 89(13):1330-1337. Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. PMID: 28855411; PMCID: PMC5649756.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsPHPublic Health
    52. Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging. Int J MS Care. 2017 May-Jun; 19(3):131-139. Obiwuru O, Joseph S, Liu L, Palomeque A, Tarlow L, Langer-Gould AM, Amezcua L. PMID: 28603461; PMCID: PMC5460866.
      View in: PubMed   Mentions: 3  
    53. Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial. Ther Adv Neurol Disord. 2017 Jan; 10(1):3-17. Berkovich R, Bakshi R, Amezcua L, Axtell RC, Cen SY, Tauhid S, Neema M, Steinman L. PMID: 28450891; PMCID: PMC5400152.
      View in: PubMed   Mentions: 5  
    54. Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans. J Child Neurol. 2016 07; 31(8):1068-73. Langille MM, Islam T, Burnett M, Amezcua L. PMID: 27021143.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    55. Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population. Clin Neurol Neurosurg. 2016 Apr; 143:71-5. Sahai-Srivastava S, Wang SL, Ugurlu C, Amezcua L. PMID: 26896785.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    56. Multiple sclerosis: review of eye movement disorders and update of disease-modifying therapies. Curr Opin Ophthalmol. 2015 Nov; 26(6):534-9. Amezcua L, Morrow MJ, Jirawuthiworavong GV. PMID: 26397889.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    57. Design and development of an ethnically-diverse imaging informatics-based eFolder system for multiple sclerosis patients. Comput Med Imaging Graph. 2015 Dec; 46 Pt 2:257-68. Ma KC, Fernandez JR, Amezcua L, Lerner A, Shiroishi MS, Liu BJ. PMID: 26564667; PMCID: PMC4936902.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    58. Multiple sclerosis in US minority populations: Clinical practice insights. Neurol Clin Pract. 2015 Apr; 5(2):132-142. Khan O, Williams MJ, Amezcua L, Javed A, Larsen KE, Smrtka JM. PMID: 26137421; PMCID: PMC4404283.
      View in: PubMed   Mentions: 48  
    59. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015 Jan 21; 85(2):296-302. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV. PMID: 25611508; PMCID: PMC4350773.
      View in: PubMed   Mentions: 898     Fields:    Translation:HumansCells
    60. Place of birth,age of immigration,and disability in Hispanics with multiple sclerosis. Mult Scler Relat Disord. 2015 Jan; 4(1):25-30. Amezcua L, Conti DV, Liu L, Ledezma K, Langer-Goulda AM. PMID: 25729639; PMCID: PMC4341972.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    61. Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult Scler. 2015 Feb; 21(2):198-205. Ebrahimi N, Herbstritt S, Gold R, Amezcua L, Koren G, Hellwig K. PMID: 25159275.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    62. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One. 2013; 8(11):e76562. Zada G, Kintz N, Pulido M, Amezcua L. PMID: 24223703; PMCID: PMC3818366.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    63. Spinal cord lesions and disability in Hispanics with multiple sclerosis. J Neurol. 2013 Nov; 260(11):2770-6. Amezcua L, Lerner A, Ledezma K, Conti D, Law M, Weiner L, Langer-Gould A. PMID: 23912723; PMCID: PMC3816004.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Vitamin D levels in Hispanics with multiple sclerosis. J Neurol. 2012 Dec; 259(12):2565-70. Amezcua L, Chung RH, Conti DV, Langer-Gould AM. PMID: 22588255.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler. 2011 Aug; 17(8):1010-6. Amezcua L, Lund BT, Weiner LP, Islam T. PMID: 21467188.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    66. Compressive neuropathies complicating normal childbirth: case report and literature review. Birth. 2007 Jun; 34(2):173-5. Sahai-Srivastava S, Amezcua L. PMID: 17542822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Lilyana's Networks
    Concepts (180)
    Derived automatically from this person's publications.
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _